SD

Saikumar Dammak

Director Director DIN 07112399
DIN 07112399 First appointment Mar 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2015
Shareholding value Locked Premium profile

About Saikumar Dammak

Data last updated:

Saikumar Dammak has 11 years in corporate governance. Formerly with 1 company, such as Novell Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07112399
Primary Designation Director
First Appointment 13 Mar 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Novell Pharma Private Limited U24230TG2015PTC098025
Director13 Mar 20152015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Novell Pharma Private Limited
Premium access

Shareholding and investment profile for Saikumar Dammak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saikumar Dammak

Saikumar Dammak has 11 years in corporate governance. Formerly with 1 company, such as Novell Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Saikumar Dammak is associated with 0 companies as a director.

Saikumar Dammak has expertise in General Business.

Saikumar Dammak has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available